A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 340,000 shares of TWST stock, worth $14.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
340,000
Previous 87,300 289.46%
Holding current value
$14.7 Million
Previous $3 Million 459.43%
% of portfolio
0.04%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$27.95 - $53.0 $7.06 Million - $13.4 Million
252,700 Added 289.46%
340,000 $16.8 Million
Q1 2024

May 15, 2024

SELL
$32.28 - $41.5 $187,224 - $240,700
-5,800 Reduced 6.23%
87,300 $3 Million
Q4 2023

Feb 14, 2024

BUY
$15.08 - $38.61 $446,368 - $1.14 Million
29,600 Added 46.61%
93,100 $3.43 Million
Q3 2023

Nov 14, 2023

SELL
$18.62 - $26.57 $249,508 - $356,038
-13,400 Reduced 17.43%
63,500 $1.29 Million
Q2 2023

Aug 14, 2023

SELL
$11.49 - $20.46 $405,597 - $722,238
-35,300 Reduced 31.46%
76,900 $1.57 Million
Q1 2023

May 15, 2023

BUY
$14.6 - $30.9 $1.41 Million - $2.98 Million
96,500 Added 614.65%
112,200 $1.69 Million
Q4 2022

Feb 14, 2023

BUY
$21.92 - $39.37 $149,056 - $267,716
6,800 Added 76.4%
15,700 $373,000
Q3 2022

Nov 14, 2022

SELL
$33.44 - $56.56 $127,071 - $214,928
-3,800 Reduced 29.92%
8,900 $314,000
Q2 2022

Aug 15, 2022

SELL
$26.2 - $54.0 $461,120 - $950,400
-17,600 Reduced 58.09%
12,700 $444,000
Q1 2022

May 16, 2022

BUY
$38.58 - $83.27 $1.17 Million - $2.52 Million
30,300 New
30,300 $1.5 Million
Q4 2021

Feb 14, 2022

SELL
$75.47 - $135.88 $324,521 - $584,284
-4,300 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$95.64 - $131.48 $1.12 Million - $1.54 Million
-11,700 Reduced 73.13%
4,300 $460,000
Q2 2021

Aug 16, 2021

SELL
$88.13 - $142.06 $2.72 Million - $4.39 Million
-30,900 Reduced 65.88%
16,000 $2.13 Million
Q1 2021

May 17, 2021

BUY
$105.48 - $207.97 $3.23 Million - $6.36 Million
30,600 Added 187.73%
46,900 $5.81 Million
Q4 2020

Feb 16, 2021

BUY
$76.64 - $167.89 $758,736 - $1.66 Million
9,900 Added 154.69%
16,300 $2.3 Million
Q2 2020

Aug 14, 2020

SELL
$26.4 - $45.3 $184,800 - $317,100
-7,000 Reduced 52.24%
6,400 $290,000
Q1 2020

May 15, 2020

BUY
$19.71 - $35.15 $264,114 - $471,010
13,400 New
13,400 $410,000
Q3 2019

Nov 14, 2019

SELL
$23.72 - $33.99 $398,496 - $571,032
-16,800 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$21.74 - $33.2 $365,232 - $557,760
16,800 New
16,800 $487,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.44B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.